Wird geladen...
Left Atrial Thrombosis Despite Dabigatran Therapy
Dabigatran is a novel anticoagulation which has been approved as an alternative to warfarin therapy for non-valvular atrial fibrillation. Use of Dabigatran for approved indications as well as off label use has dramatically increased after Federal Drug Administration (FDA) approval. Our patient had l...
Gespeichert in:
| Veröffentlicht in: | J Atr Fibrillation |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cardiofront, Inc
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153238/ https://ncbi.nlm.nih.gov/pubmed/28496880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.891 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|